Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas M. Bridges is active.

Publication


Featured researches published by Thomas M. Bridges.


Archive | 2010

Discovery of a Highly Selective in vitro and in vivo M4 Positive Allosteric Modulator (PAM)

L. Michelle Lewis; Thomas M. Bridges; Colleen M. Niswender; C. David Weaver; Craig W. Lindsley


Archive | 2013

Identification of a glycine sulfonamide based non-MPEP site positive allosteric potentiator (PAM) of mGlu5

Alice L. Rodriguez; James C. Tarr; Ya Zhou; Richard Williams; Karen J. Gregory; Thomas M. Bridges; J. Scott Daniels; Colleen M. Niswender; P. Jeffrey Conn; Craig W. Lindsley; Shaun R. Stauffer


Archive | 2013

Pure Positive Allosteric Modulators (PAMs) of mGlu5 with Competitive MPEP-Site Interaction

Ya Zhou; Aspen Chun; Rocco D. Gogliotti; Eric S. Dawson; Paige N. Vinson; Colleen M. Niswender; Meredith J. Noetzel; Jerri M. Rook; Thomas M. Bridges; J. Scott Daniels; Carrie K. Jones; P. Jeffrey Conn; Craig W. Lindsley; Shaun R. Stauffer


Archive | 2010

Amidobipiperidinecarboxylate m1 allosteric agonists, analogs and derivatives thereof, and methods of making and using same

Craig W. Lindsley; Jeffrey P. Conn; Charles David Weaver; Colleen M. Niswender; Evan P. Lebois; Thomas M. Bridges


Archive | 2013

Discovery of a Highly Selective in vitro and in vivo M4 Positive Allosteric Modulator (PAM) Series with Greatly Improved Human Receptor Activity

Thomas M. Bridges; Colleen M. Niswender; Carrie K. Jones; L. Michelle Lewis; C. David Weaver; Michael R. Wood; J. Scott Daniels; P. Jeffrey Conn; Craig W. Lindsley


Archive | 2013

Identification of a Selective Allosteric Agonist of mGlu5

Jason Manka; Ya Zhou; Aspen Chun; Eric S. Dawson; Paige N. Vinson; Colleen M. Niswender; Meredith J. Noetzel; Jerri M. Rook; Thomas M. Bridges; J. Scott Daniels; Carrie K. Jones; P. Jeffrey Conn; Craig W. Lindsley; Shaun R. Stauffer


Archive | 2015

Development of the First CNS penetrant M5 Positive Allosteric Modulator (PAM) Based on a Novel, non-Isatin Core

Patrick R. Gentry; Masaya Kokubo; Thomas M. Bridges; J. Scott Daniels; Colleen M. Niswender; Emery Smith; Peter Chase; Peter Hodder; Hugh Rosen; P. Jeffrey Conn; Julie L. Engers; Katrina A. Brewer; Craig W. Lindsley; Michael R. Wood


Archive | 2013

Figure 4, HTS single-point hit

Patrick R. Gentry; Thomas M. Bridges; J. Scott Daniels; Atin Lamsal; Paige N. Vinson; Colleen M. Niswender; Peter Hodder; Hugh Rosen; P. Jeffrey Conn; Julie L. Engers; Craig W. Lindsley; Michael R. Wood


Archive | 2013

Table 5, Pan Labs profiling of ML326 and selected results for ML172

Patrick R. Gentry; Thomas M. Bridges; J. Scott Daniels; Atin Lamsal; Paige N. Vinson; Colleen M. Niswender; Peter Hodder; Hugh Rosen; P. Jeffrey Conn; Julie L. Engers; Craig W. Lindsley; Michael R. Wood


Archive | 2013

Figure 1, Synthetic procedure and spectral data for ML254 (CID 46926631, SID 125305189)

Ya Zhou; Aspen Chun; Rocco D. Gogliotti; Eric S. Dawson; Paige N. Vinson; Colleen M. Niswender; Meredith J. Noetzel; Jerri M. Rook; Thomas M. Bridges; J. Scott Daniels; Carrie K. Jones; P. Jeffrey Conn; Craig W. Lindsley; Shaun R. Stauffer

Collaboration


Dive into the Thomas M. Bridges's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Scott Daniels

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge